CAMP4 Financial Statements From 2010 to 2025
| CAMP Stock | USD 1.63 0.02 1.21% |
Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as , as well as many indicators such as . CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
Check out the analysis of CAMP4 THERAPEUTICS Correlation against competitors. CAMP4 THERAPEUTICS PORATION Company Shares Owned By Institutions Analysis
CAMP4 THERAPEUTICS's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current CAMP4 THERAPEUTICS Shares Owned By Institutions | 56.95 % |
Most of CAMP4 THERAPEUTICS's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CAMP4 THERAPEUTICS PORATION is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 56% of CAMP4 THERAPEUTICS PORATION are shares owned by institutions. This is 24.79% higher than that of the Biotechnology sector and 18.78% higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 45.25% lower than that of the firm.
CAMP4 THERAPEUTICS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CAMP4 THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare CAMP4 THERAPEUTICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CAMP4 THERAPEUTICS competition to find correlations between indicators driving CAMP4 THERAPEUTICS's intrinsic value. More Info.CAMP4 THERAPEUTICS PORATION is the top company in current valuation category among its peers. It also is number one stock in shares outstanding category among its peers creating about 0.18 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for CAMP4 THERAPEUTICS PORATION is roughly 5.44 . Comparative valuation analysis is a catch-all technique that is used if you cannot value CAMP4 THERAPEUTICS by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About CAMP4 THERAPEUTICS Financial Statements
CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company was incorporated in 1981 and is headquartered in Irvine, California. CalAmp Corp operates under Communication Equipment classification in the United States and is traded on NASDAQ Exchange. It employs 887 people.
Pair Trading with CAMP4 THERAPEUTICS
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.Moving together with CAMP4 Stock
Moving against CAMP4 Stock
| 0.71 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.71 | CICHF | China Construction Bank | PairCorr |
| 0.63 | BNTX | BioNTech SE Earnings Call This Week | PairCorr |
| 0.61 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.6 | MRK | Merck Company | PairCorr |
The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.